Literature DB >> 31895150

Elite suppressors have low frequencies of intact HIV-1 proviral DNA.

Abena Kr Kwaa1, Caroline C Garliss1, Kristen D Ritter2, Gregory M Laird2, Joel N Blankson1.   

Abstract

: Elite controllers or suppressors control viral replication without antiretroviral therapy. We used the intact proviral DNA assay to approximate the size of the inducible latent reservoir in elite suppressors and found that, while the median frequency of both total and intact proviral DNA was markedly lower than the frequencies seen in chronic progressors on antiretroviral therapy there was no significant difference in the ratio of intact to total proviral DNA between elite suppressors and chronic progressors.

Entities:  

Mesh:

Year:  2020        PMID: 31895150      PMCID: PMC7610219          DOI: 10.1097/QAD.0000000000002474

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  26 in total

1.  HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.

Authors:  Maria Salgado; Michael D Swanson; Christopher W Pohlmeyer; Robert W Buckheit; Jin Wu; Nancie M Archin; Thomas M Williams; David M Margolis; Robert F Siliciano; J Victor Garcia; Joel N Blankson
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

2.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

3.  Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.

Authors:  Nicolas Noel; Ruth Peña; Annie David; Veronique Avettand-Fenoel; Itziar Erkizia; Esther Jimenez; Camille Lecuroux; Christine Rouzioux; Faroudy Boufassa; Gianfranco Pancino; Alain Venet; Carine Van Lint; Javier Martinez-Picado; Olivier Lambotte; Asier Sáez-Cirión; Julia G Prado
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

4.  Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.

Authors:  Justin R Bailey; Karen O'Connell; Hung-Chih Yang; Yefei Han; Jie Xu; Benjamin Jilek; Thomas M Williams; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

5.  Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.

Authors:  Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Joan Dunn-Williams; Peter W Hunt; Rebecca Hoh; Susan L Stramer; Jeffrey M Linnen; Joseph M McCune; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

6.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Authors:  Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Christiane Deveau; Martine Sinet; Julien Guergnon; Valérie Courgnaud; Christine Rouzioux; Jean-François Delfraissy; Alain Venet; Laurence Meyer
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

7.  Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.

Authors:  Erin H Graf; Angela M Mexas; Jianqing J Yu; Farida Shaheen; Megan K Liszewski; Michele Di Mascio; Stephen A Migueles; Mark Connors; Una O'Doherty
Journal:  PLoS Pathog       Date:  2011-02-24       Impact factor: 6.823

8.  Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation

.

Authors:  Christopher W Pohlmyer; C Korin Bullen; Alyssa R Martin; Gregory M Laird; Stanley U Chioma; Victoria E K Walker-Sperling; Joel N Blankson
Journal:  Yale J Biol Med       Date:  2017-06-23

9.  Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.

Authors:  Susanne Eriksson; Erin H Graf; Viktor Dahl; Matthew C Strain; Steven A Yukl; Elena S Lysenko; Ronald J Bosch; Jun Lai; Stanley Chioma; Fatemeh Emad; Mohamed Abdel-Mohsen; Rebecca Hoh; Frederick Hecht; Peter Hunt; Ma Somsouk; Joseph Wong; Rowena Johnston; Robert F Siliciano; Douglas D Richman; Una O'Doherty; Sarah Palmer; Steven G Deeks; Janet D Siliciano
Journal:  PLoS Pathog       Date:  2013-02-14       Impact factor: 6.823

10.  Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

Authors:  Marcial García; Miguel Górgolas; Alfonso Cabello; Vicente Estrada; José Manuel Ligos; Manuel Fernández-Guerrero; Carlos Barros; Juan Carlos López-Bernaldo; Francisco Javier De La Hera; María Montoya; José Miguel Benito; Norma Rallón
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more
  7 in total

1.  Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.

Authors:  Francesco R Simonetti; Jennifer A White; Camille Tumiotto; Kristen D Ritter; Mian Cai; Rajesh T Gandhi; Steven G Deeks; Bonnie J Howell; Luis J Montaner; Joel N Blankson; Albine Martin; Gregory M Laird; Robert F Siliciano; John W Mellors; Janet D Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-20       Impact factor: 11.205

2.  QnAs with Joel N. Blankson.

Authors:  Matthew Hardcastle
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

Review 3.  Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.

Authors:  Janet D Siliciano; Robert F Siliciano
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

4.  HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA).

Authors:  Natalie N Kinloch; Yanqin Ren; Winiffer D Conce Alberto; Winnie Dong; Pragya Khadka; Szu Han Huang; Talia M Mota; Andrew Wilson; Aniqa Shahid; Don Kirkby; Marianne Harris; Colin Kovacs; Erika Benko; Mario A Ostrowski; Perla M Del Rio Estrada; Avery Wimpelberg; Christopher Cannon; W David Hardy; Lynsay MacLaren; Harris Goldstein; Chanson J Brumme; Guinevere Q Lee; Rebecca M Lynch; Zabrina L Brumme; R Brad Jones
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 14.919

5.  HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.

Authors:  F Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N Kinloch; Bradley R Jones; Rachel L Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A Brockman; Chanson J Brumme; Jeffrey B Joy; Richard Liang; Bruce D Walker; Zabrina L Brumme
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

Review 6.  How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.

Authors:  Jonathan Z Li; Joel N Blankson
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

7.  Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication.

Authors:  Marilia R Pinzone; Sam Weissman; Alexander O Pasternak; Ryan Zurakowski; Stephen Migueles; Una O'Doherty
Journal:  JCI Insight       Date:  2021-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.